These results support the notion that PGD2 and perhaps its metabolites, are key to the pathological demyelination occurring in the twitcher mouse, and the neuroprotective potential of manipulating the PGD2-signaling to overcome demyelination in Krabbe disease (Mohri et al., 2006; Bosetti, 2007). The gene discussed is PTGDS; the disease is Krabbe disease.